Rchr
J-GLOBAL ID:202001015056719354   Update date: May. 04, 2024

Satoh Taroh

サトウ タロウ | Satoh Taroh
Affiliation and department:
Job title: associate professor
Other affiliations (1):
  • Osaka University
Research theme for competitive and other funds  (8):
  • 2023 - 2025 外来がん薬物療法を受ける高齢がん患者の聴覚可視化による有効なセルフケア支援の検討
  • 2022 - 2025 Elucidation of the whole pancreatic cancer methylome and development of control method
  • 2019 - 2022 Development of artificial intelligence system to support postoperative chemotherapy
  • 2018 - 2021 Elucidation and application of early brain metastasis mechanism by Warburg regulator MPC
  • 2016 - 2018 New development of epigenome drug discovery to realize oncogene selectivity
Show all
Papers (338):
  • Daisuke Kotani, Atsuo Takashima, Takeshi Kato, Taroh Satoh, Toshiki Masuishi, Yoshito Komatsu, Manabu Shiozawa, Taito Esaki, Naoki Izawa, Shinji Takeuchi, et al. Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program. Clinical colorectal cancer. 2024
  • Shinsuke Hara, Daisuke Sakai, Kenji Ikemura, Takuya Shintani, Tomoya Yamamoto, Taroh Satoh, Masahiro Okuda. Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer. Anticancer research. 2024. 44. 3. 1219-1226
  • Tomono Kawase, Hiroshi Imamura, Ryohei Kawabata, Jin Matsuyama, Kazuhiro Nishikawa, Kazuhiro Yanagihara, Kazuyoshi Yamamoto, Noriyuki Hoki, Junji Kawada, Hisato Kawakami, et al. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902). International journal of clinical oncology. 2024. 29. 2. 134-141
  • Ryo Mitsui, Shun Kasahara, Shuji Uchida, Takuya Shimooka, Kohei Kawamura, Takayuki Hara, Shin-ichiro Hiraoka, Hisao Sano, Susumu Tanaka, Taroh Satoh. A case of eosinophilic gastroenteritis developed during administration of nivolumab for a patient with platinum-resistant head and neck cancer. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2024
  • Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Akiyoshi Kanazawa, Koji Ando, et al. Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study. Clinical colorectal cancer. 2024
more...
MISC (199):
  • 王谷 英達, 畑毛 一枝, 坂井 大介, 佐藤 太郎, 伊村 慶紀, 中井 隆彰, 名井 陽, 岡田 誠司. ゲノム医療時代の骨・軟部腫瘍医 肉腫診療におけるがんゲノム医療の実際. 日本整形外科学会雑誌. 2022. 96. 6. S1284-S1284
  • 大鶴 徹, 山口 敏史, 武本 憲彦, 坂井 大介, 佐藤 太郎, 池田 公史. Minimal/molecular residual disease(MRD). 腫瘍内科. 2022. 29. 3. 371-376
  • Masatoshi Kitakaze, Masamitsu Konno, Ayumu Asai, Ryota Chijimatsu, Shiki Fujino, Takayuki Ogino, Hidekazu Takahashi, Norikatsu Miyoshi, Mamoru Uemura, Taroh Satoh, et al. Single-cell analysis of immune cells in tumor reveals the function of resident memory T cells in colorectal tumor. CANCER SCIENCE. 2022. 113
  • 石塚保亘, 山口敏史, 佐藤太郎. Regimens of Anti-EGFR and HER2 Antibody Drugs. 臨床消化器内科. 2022. 37. 11
  • Satoshi Yuki, Yoshiaki Nakamura, Hiroya Taniguchi, Tadamichi Denda, Tomohiro Nishina, Yasuo Hamamoto, Hiroki Hara, Taito Esaki, Hisato Kawakami, Atsuo Takashima, et al. Expression of PD-L1 and PD-L2 in colorectal cancer (CRC): A post-hoc integrated analysis of SCRUM-Japan GI-SCREEN CRC. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
more...
Association Membership(s) (8):
日本食道学会 ,  日本臨床腫瘍学会 ,  日本癌学会 ,  日本癌治療学会 ,  日本消化器内視鏡学会 ,  日本胃癌学会 ,  日本内科学会 ,  日本消化器病学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page